3
Total investments
2
Early stage
0
Mid stage
0
Late stage
11y
Years active
Portfolio
3 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor and Strategic Advisor
Aug 2019
Our women-led team has created the first speculum designed with the patient in mind.
Advances in womens healthcare continue to lag far behind those seen in other healthcare fields. We know the experience can be better for both patients and providers. Our goal is to address these unmet needs and develop products that transform every patients experience in the exam room.
At Ceek Womens Health, we believe a human-centered design approach leads to products that improve gynecological care for all.
Our Nella® product line includes the NuSpec®, a redesigned vaginal speculum built for patient comfort, the VuSleeve®, an innovative single-use sheath, and the VuLight®, a single-use LED illuminator.
Investor and Advisor
Nov 2018
RwHealth is a provider of healthcare analytics and data solutions, that has helped clients across the UK, Middle East and Australia with their mission-critical programs. As informatics specialists with more than 10 years’ experience, we blend industry expertise and advanced technology to deliver the most accurate perspectives and in-depth analytics. Our solutions drive actionable insights, powered by superior information assets, which we tune to our client’s precise requirements.
We continuously innovate to keep pace with a global healthcare environment which is increasingly complex and interdependent. Whether our clients are decision makers in Primary, Secondary or Tertiary Care, our analytical, and solution capabilities are key to competitive advantage – and to achieving high quality, cost-effective healthcare.
RwHealth has a suite of enterprise applications that provide healthcare organisations with the health intelligence solutions they need to realise quality, safety, and efficiency.
Board Member
Dec 2015
Evofem Biosciences, Inc., (OTCQB: EVFM) is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health
In September 2020, Evofem launched Phexxi, the first and only hormone-free, on-demand, prescription birth control available in the U.S. that women use only when they have sex.
Experience · 8 entries
All (8)
Investments (3)
Founder (5)
Board (1)
2026
Co-Founder and Investor Director
Jan 2026
Maprium enables pharmaceutical and biotech companies to design, manage and govern Managed Access Programs globally.
As innovation accelerates, access remains the primary bottleneck for patients. Managed Access — also known as Expanded Access, Compassionate Use, Named Patient and Post-Trial Access — is now a strategic, regulatory and ethical requirement. Yet many organisations still rely on fragmented tools, manual processes and vendor-owned systems to manage complex global programmes.
Maprium provides the digital infrastructure for Managed Access.
Our platform embeds regulatory, medical and safety requirements into configurable, country-aware workflows, giving sponsors full visibility, control and auditability across programmes and geographies. Unlike service-led models, Maprium is sponsor-owned and vendor-agnostic, enabling companies to retain ownership of their data, governance and long-term access strategy while working with preferred partners.
Built specifically for regulated life sciences environments, Maprium supports equitable, compliant and scalable access to medicines — without compromising control or data integrity.
Built for compliance. Built for scale. Built for pharma.
2020
Co-Founder
Jan 2020
RealiTi was founded by leaders who envisioned and helped build the global managed access industry, along with experts in rare diseases, technology, data science, patient support and homecare services. A team of highly skilled experienced pharmaceutical and clinical professionals, we are practitioners, not consultants. With hands on experience at the sharp end of patient care and delivering many international programs, we know what’s essential and important to patients in need of complex care.
2019
Investor and Strategic Advisor
Aug 2019
Our women-led team has created the first speculum designed with the patient in mind.
Advances in womens healthcare continue to lag far behind those seen in other healthcare fields. We know the experience can be better for both patients and providers. Our goal is to address these unmet needs and develop products that transform every patients experience in the exam room.
At Ceek Womens Health, we believe a human-centered design approach leads to products that improve gynecological care for all.
Our Nella® product line includes the NuSpec®, a redesigned vaginal speculum built for patient comfort, the VuSleeve®, an innovative single-use sheath, and the VuLight®, a single-use LED illuminator.
2018
Investor and Advisor
Nov 2018
RwHealth is a provider of healthcare analytics and data solutions, that has helped clients across the UK, Middle East and Australia with their mission-critical programs. As informatics specialists with more than 10 years’ experience, we blend industry expertise and advanced technology to deliver the most accurate perspectives and in-depth analytics. Our solutions drive actionable insights, powered by superior information assets, which we tune to our client’s precise requirements.
We continuously innovate to keep pace with a global healthcare environment which is increasingly complex and interdependent. Whether our clients are decision makers in Primary, Secondary or Tertiary Care, our analytical, and solution capabilities are key to competitive advantage – and to achieving high quality, cost-effective healthcare.
RwHealth has a suite of enterprise applications that provide healthcare organisations with the health intelligence solutions they need to realise quality, safety, and efficiency.
L
Lucidity LLC
Chairman and founder
Sep 2018
Show all 8 entries ↓
Investment activity
2015–2019 · 3 investments
Recent (last 2 years)Earlier
Similar investors
Manufacturing early-stage investors in United States
Investor lists
Lists that match Natalie's portfolio
- Manufacturing early-stage investors in United States2,280 investors
- Consulting early-stage investors in United States2,224 investors
- Biotechnology early-stage investors in United States2,072 investors
- Early-stage startup investors in United States3,677 investors






